title: Immunotherapy of hepatocellular carcinoma with a vaccine based on xenogeneic homologous alpha fetoprotein in mice.
abstract: alpha-Fetoprotein (AFP) is a diagnostic marker for the presence of hepatocellular carcinoma, and a potential target for immunotherapy. Unfortunately, the immunity to AFP is presumably difficult to elicit because of immune tolerance acquired during the development of immune system. In the present study, we used AFP as a model antigen to explore the feasibility of the immunotherapy of AFP-positive liver cancer by the breaking of immune tolerance against AFP in a cross-reaction between the xenogeneic homologues and self molecules. Recombinant rat AFP was prepared as a vaccine, and mouse AFP was prepared as a control. Immunized with rat AFP was effective at protective and therapeutic antitumor immunity in hepatocellular carcinoma model in mice. Both humoral and cellular immune responses may be responsible for the antitumor activity against AFP-positive tumor cells, and no marked side effects were observed in the immunized mice. Thus, our study may provide an effective vaccine strategy for the treatment of AFP-positive hepatocellular carcinoma, and may be of importance to further exploration of the breaking of immune tolerance to self molecules.
authors: State Key Laboratory of Biotherapy, West China Hospital, West China Medical School, Sichuan University, Gao Xin Qu Ke Yuan 4th Road No. 1, Chengdu, Sichuan, People's Republic of China.
authors: Wei
authors: W
authors: Zhang
authors: Jiyan
authors: J
authors: Liu
authors: Yang
authors: Y
authors: Wu
authors: Fei
authors: F
authors: Xiao
authors: Younsheng
authors: Y
authors: Wang
authors: Rui
authors: R
authors: Wang
authors: Hanshuo
authors: H
authors: Yang
authors: Guoqing
authors: G
authors: Wang
authors: Jinliang
authors: J
authors: Yang
authors: Hongxin
authors: H
authors: Deng
authors: Jiong
authors: J
authors: Li
authors: Yanjun
authors: Y
authors: Wen
authors: Yuquan
authors: Y
authors: Wei
mesh_terms: D000818:Animals; D000912:Antibodies, Neoplasm / Q000097:blood / Q000276:immunology; D019496:Cancer Vaccines / Q000235:genetics / Q000276:immunology* / Q000627:therapeutic use*; D006528:Carcinoma, Hepatocellular / Q000276:immunology / Q000628:therapy*; D045744:Cell Line, Tumor; D007108:Immune Tolerance; D007167:Immunotherapy / Q000379:methods; D008113:Liver Neoplasms / Q000276:immunology / Q000628:therapy*; D051379:Mice; D008810:Mice, Inbred C57BL; D051381:Rats; D011994:Recombinant Proteins / Q000235:genetics / Q000276:immunology / Q000627:therapeutic use; D000509:alpha-Fetoproteins / Q000235:genetics / Q000276:immunology* / Q000627:therapeutic use*
chemical_list: D000912:Antibodies, Neoplasm; D019496:Cancer Vaccines; D011994:Recombinant Proteins; D000509:alpha-Fetoproteins